FDA Clearance Tracker · P170042-S011
Covera Vascular Covered Stent
Last checked: Nov 20, 2026Latest source record: Mar 24, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Mar 24, 2022
Approved
Time to decision
216 days
Received Aug 20, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P170042-S011
- Device name
- Covera Vascular Covered Stent
- Applicant
- C.R. Bard, Inc.
- Applicant location
- Tempe, AZ
- Received
- Aug 20, 2021
- Decided
- Mar 24, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P170042
Device type
- Device type
- System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for an update to the labeling to include the 36-month data on patients enrolled in the AVeNEW IDE extended follow-up study.
Source documents
Other decisions for C.R. Bard, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261543 · Decided Sep 28, 2026 · 143 days after receipt
Device type: Mesh, Surgical, Absorbable, Abdominal Hernia (OWT) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.